29th October 2026, Thursday

TechPharus

Latest Posts

HealthTech News

  • Meal delivery apps could be driving us toward unhealthy choices
    on October 29, 2026 at 3:00 am

    New research has revealed how meal delivery apps are steering Australians toward unhealthy food options, prompting calls from experts for government action to reset the balance and make choosing healthy options easier and more affordable.

  • Can an AI chatbot help women recognize heart disease?
    on October 29, 2026 at 2:00 am

    HeartBot, created by a team of UC researchers, regularly answers questions from women seeking information on heart disease. The project was led by Yoshimi Fukuoka, Ph.D., RN, FAAN, a nurse scientist and professor at UC San Francisco’s School of Nursing. The goal was to study whether having a heart-health chatbot on their phone would increase study participants’ awareness of heart disease risks and recognition of heart attack symptoms so they would seek medical help when necessary.

  • Recommendations developed for management of hidradenitis suppurativa
    on October 29, 2026 at 1:00 am

    Evidence-based recommendations are presented for the management of hidradenitis suppurativa (HS) in guidelines of care issued by the American Academy of Dermatology and the Hidradenitis Suppurativa Foundation and published online Oct. 20 in the Journal of the American Academy of Dermatology.

  • Video decision aid increases advance care planning in seniors with chronic kidney disease
    on October 29, 2026 at 12:00 am

    Among older adults with advanced chronic kidney disease (CKD), a video decision aid increases advance care planning (ACP) documentation in the electronic health record, according to a study published in JAMA Internal Medicine to coincide with Kidney Week, the annual meeting of the American Society of Nephrology, held from Oct. 21 to 25 in Denver.

  • Achilles injections show no meaningful benefit over sham treatment
    on October 28, 2026 at 10:30 pm

    Commonly used injections for Achilles tendinopathy—pain, stiffness and swelling in the Achilles tendon—offer no meaningful clinical advantage over placebo (sham) treatment, finds a clinical trial published by The BMJ.